Nicholas Brendon was open with fans about his health before his untimely death at 54. The actor, best known for playing the lovable and wisecracking Xander Harris on “Buffy the Vampire Slayer,” died ...

LEO Pharma A/S, a global leader in medical dermatology, today announced it will present 17 scientific posters at the 2026 American Academy of Dermatology (AAD) Annual Meeting (March 27-31, Denver, ...

Body integrity dysphoria is a rare and complex condition in which individuals experience a persistent and distressing desire ...

Promising Phase 2a data announced for izicopan, underscoring its potential as a meaningfully differentiated, effective and safe oral inhibitor of ...

InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced an oral presentation during the Late-Breaking ...

Skin issues are one of the most common reasons pets end up at the vet. For many itchy dogs and cats, the underlying problem is pyoderma, a bacterial infection of ...

President Donald Trump called for Republicans to "nationalize" the voting process during a recent appearance on the podcast of Dan Bongino. Trump's statements are directly tied to his continued ...

The definition is tricky, but the effects of poor metabolic health are clear — and can wreak havoc on the body. By Nina Agrawal “Metabolic health” is a wellness catchphrase that is hard to escape.

ABSTRACT: Pyoderma Gangrenosum (PG) is an autoinflammatory condition mimicking Surgical Site Infection in the postoperative period and both these conditions differ entirely in terms of their ...

Stripe is a payment service provider that accepts credit cards, digital wallets and many other payment methods. Many, or all, of the products featured on this page are from our advertising partners ...

1 Department of Cardio Thoracic and Vascular Surgery, All India Institute of Medical Sciences, Raipur, India. 2 Department of Cardio Thoracic and Vascular Surgery, Sri Padmavathi Children’s Heart ...

While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to futility regarding its prespecified primary endpoint (as previously disclosed), ...